According to Bio-Rad Laboratories's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 5.04305. At the end of 2022 the company had a P/S ratio of 4.42.
Year | P/S ratio | Change |
---|---|---|
2022 | 4.42 | -42.44% |
2021 | 7.68 | 12.69% |
2020 | 6.81 | 42.27% |
2019 | 4.79 | 58.7% |
2018 | 3.02 | -8.21% |
2017 | 3.29 | 26.16% |
2016 | 2.61 | 29.42% |
2015 | 2.01 | 24.97% |
2014 | 1.61 | -3.41% |
2013 | 1.67 | 15.56% |
2012 | 1.44 | 10.98% |
2011 | 1.30 | -13.45% |
2010 | 1.50 | 0.72% |
2009 | 1.49 | 28.08% |
2008 | 1.16 | -38.9% |
2007 | 1.91 | 11.06% |
2006 | 1.72 | 18.14% |
2005 | 1.45 | 7.26% |
2004 | 1.35 | -8.1% |
2003 | 1.47 | 34.69% |
2002 | 1.09 | 11.81% |
2001 | 0.9789 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | 5.09 | 0.96% | ๐บ๐ธ USA |
![]() Thermo Fisher Scientific TMO | 4.95 | -1.92% | ๐บ๐ธ USA |
![]() Agilent Technologies A | 5.96 | 18.14% | ๐บ๐ธ USA |
![]() Becton Dickinson BDX | 3.69 | -26.73% | ๐บ๐ธ USA |
![]() General Electric GE | 1.37 | -72.74% | ๐บ๐ธ USA |
![]() Danaher DHR | 5.85 | 16.07% | ๐บ๐ธ USA |
![]() PerkinElmer
PKI | 4.30 | -14.66% | ๐บ๐ธ USA |